GSK (GLAXOSMITHKLINE P)
All Pro Portfolios with GSK
- Total Pro Portfolios with GSK:
- Allianz NFJ Dividend Value Instl NFJEX
- Dodge & Cox
- Dodge & Cox Stock (DODGX)
- BAM Capital
- Vanguard PRIMECAP Core - VPCCX
- Dodge & Cox International Stock DODFX
- show more
- 12
- Kinetics Medical MEDRX
- Tweedy Browne
- Renaissance Technologies
- WisdomTree Intl Consumer Non-Cyclical Fund (DPN)
- Homestead Value - HOVLX
- Oakmark International Fund (OAKIX)
All Do-It-Yourself Portfolios with GSK
- Total Do-It-Yourself Portfolios with GSK:
- Vitaliy's Top Stocks
- Jim Profit
- Christina Agnew Portfolio 1
- bdove
- biosci
- aapl
- coyote Portfolio 1
- smtm
- BMO Investment
- mcD
- Scotts' MadMoney
- Ellen's Portfolio
- 5 Breakthrough Drugs for 2007
- j_b Portfolio 1
- john matera Portfolio 1
- Phil Kempton Portfolio 1
- SPIKES BIG
- bobbi Portfolio 1a
- Nish Deodhar Portfolio 1
- JohnnyRocker Portfolio 1
- Today
- machoger
- mark one
- Catherine Meyerholtz Portfolio 1
- Ulrath_the_Unclean Portfolio 1
- Top Yielding Healthcare Stocks
- Stallion Capital
- semtax Portfolio 1
- helen
- tapin67
- erbarden Portfolio 1
- ruesew Portfolio 1
- mypharma
- TW Growth
- markastevenson Portfolio 1
- How To Play A Rate Hike
- killer bees
- AFree Portfolio 1
- PhishyAl's Portfolio
- nhjackson Portfolio 1
- BACKUP PORTFOLIO
- Schroeders Portfolio
- youngmiss Portfolio 1
- trader6 Portfolio 1
- kEV;S CURRENT HAND
- acsutherland Portfolio 1
- bryon Portfolio 1
- JOtter Portfolio 1
- SUPRATRADE BIOTECH
- the portfolio
- jgbchbum@aol.com Portfolio 1
- show more
- 323
- beau2006
- chuck riebe Portfolio 1
- swrcurrent
- Tung Thai
- EOPIC
- schwab trust
- Jim Bufkins Portfolio 1
- Manny Mendelson Portfolio 1
- FJS Portfolio 1
- run today
- Roger1000 Portfolio 1
- samkati Portfolio 1
- kpennick1
- Randall Cox Portfolio 1
- MeriBrad
- sobiech
- Wilanow World Stocks
- MAFV Portfolio 1
- sailor1 Portfolio
- neo
- sailboat Portfolio 1
- StartUp
- Tom Van Meter Portfolio 1
- Homework
- StockpickrDotCom Portfolio 1
- W FRAZIER BRINLEY Portfolio 1
- Women of Worth-Trading
- kboerner Portfolio 1
- 2007 stock run
- my updated portfolio
- omeow Portfolio 1
- Wandas
- rcm727 Portfolio 1
- Gangbusters
- Barron's Summary 2-26-07
- Economic Indicator - Rate Hike/Recession/Inflation
- deetharris Portfolio 1
- wacman Portfolio 1
- diamondPortfolio 1
- only maybe
- WH Portfolio
- justin06 Portfolio 1
- rdrake Portfolio 1
- TZ's Holdings
- ybormel Portfolio 1
- vision2000 Portfolio 1
- gasgan22 Portfolio 1
- HEMONOSTIX STOCKS
- mustgofaster yield plus allocation
- My 23
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- Shocker Stock: Gilead
- show more
- 11/19/08
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:biancofj |
Date:11 25 08 |
sound |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Shocker Stock: Gilead: Stephanie Link, director of research for the Action Alerts Plus Portfolio, defends her team's stake in Gilead even though it has no dividend and faces stiff competition. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:11 08 08 |
With pharma shares down only 11% in a year that has seen many stocks crater by 30% or 40% or 50%, the industry's charms aren't exactly undiscovered. Still, Roche Holdings (RHHBY) and Novartis (NVS) remain in the Morgan Stanley European model portfolio, and could continue to outperform, Draaisma says. GlaxoSmithKline (GSK) derives about 45% of sales from the U.S., and also could be helped by a higher buck. Historically, price increases in all three drug stocks have been among the most highly correlated with a rising dollar. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:11 08 08 |
Drug companies could take some big hits as Democrats struggle to hammer out a workable universal-health-care scheme. Obama and Democrats in Congress are intent on bringing down the costs of drugs and services. Drug makers fear losses in revenue as Democrats push to negotiate lower drug prices under Medicare. Shares of Pfizer (PFE) and GlaxoSmithKline (GSK) both fell 8% the day after the election. Each stock is trading roughly 30% below its 52-week high. |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:10 20 08 |
5.5% |
|
Not yet rated
Rate now:
|
|
By:ron2075sc |
Date:10 14 08 |
strong co. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:10 11 08 |
Stubbs likes telecom, pharmaceutical and insurance sectors in general. For those who haven't completely soured on equity, the strategist has screened for stocks that offer a dividend yield above 4%; strong cash flow; decent dividend cover; a good balance sheet and a positive earnings picture. Among the names on this list: ENI (ticker: E); Vodafone Group (VOD), France Telecom (FTE); GlaxoSmithKline (GSK) and AstraZeneca (AZN). |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Mad About Options: GlaxoSmithKline: The Mad About Options crew reviews Jim Cramer's recent long-term bullish comments about GlaxoSmithKline and offers options strategies for traders and investors. Also hear options ideas for General Motors and Citigroup. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Cramer: Stocks Ripe for Euro Takeover |
|
Not yet rated
Rate now:
|
|
By:gadams11 |
Date:05 02 08 |
Following pro portfolio |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:kl1070 |
Date:08 06 08 |
risky |
|
Not yet rated
Rate now:
|
|
By:Bevy |
Date:03 15 07 |
? |
|
Not yet rated
Rate now:
|
|
By:wandra2 |
Date:02 17 07 |
growth and income |
|
Not yet rated
Rate now:
|
|
By:reg stith |
Date:01 14 07 |
Like the dividend and believe it too be undervalued. Good pipeline. |
|
Not yet rated
Rate now:
|
|